Decades of research show the mercury-containing preservative thimerosal is safe in vaccines, but CDC's new advisory panel is ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

“In our results, a substantial proportion of infections was prevented when transmissibility was similar to that encountered in typical influenza seasons, vaccine effectiveness was within the ranges ...

The vaccine will offer protection against H5N1 and is projected to be effective against future viral mutations.

During monsoons, influenza is among the most prevalent viral infections, spreading quickly among kids. So, vaccination before rains set in is crucial. Here's why.

New analysis warns that suboptimal clinical trial designs and overreliance on surrogate markers may allow less effective flu ...

Elanco Animal Health said on Wednesday the U.S. Department of Agriculture (USDA) has approved its canine flu vaccine, which ...

In just 3 years, the Influenza Vaccines Research and Development (R&D) Roadmap Initiative has demonstrated important ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

The federal government should approve a vaccine against highly pathogenic avian influenza (HPAI) in dairy cattle, the ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant that enhances the body's ...